New York Methodist Hospital
New York, 11215, United States
NCT Number: NCT02683993
Twenty (20) subjects presenting with a renal stone and candidates for FURS (flexible ureteroscopic renal surgery) will undergo a single FURS procedure for a kidney stone as part of the study, using the study device. These subjects will be randomized into stone breaking treatment or stone dusting.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
New York, 11215, United States
This is a randomized, two-arm, prospective, single center study. Subjects will undergo a single flexible ureteroscopic renal surgery (FURS) procedure for a kidney stone as part of this study, using the study device, and will be treated as randomized to either stone breaking treatment or stone dusting treatment. Follow up visits are scheduled for the day of release from the hospital and at 1 month post procedure. Additional treatment sessions, if required, will be at the discretion of the investigator, as part of the site standard of practice. Additional treatment sessions will not be included in this study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Lumenis Pulse P120H will be utilized in high and low frequencies according to subjects group allocation.
Time frame: Stone clearance based on 1 month follow-up imaging data
stone clearance will be confirmed by CT or X-Ray at 1 month follow up.
Time frame: Post-procedure through hospital discharge; typically discharge occurs on the same day or 1 day post procedure
Post-procedure catheterization by group
Time frame: during the procedure
Duration (in minutes) of the procedure as an indicator for treatment efficiency.
Time frame: as measured during the procedure
The need of the surgeon to use baskets, forceps or saline flushing to achieve complete stone clearance. This outcome can influence both procedure time and further complication.
Time frame: Procedure through hospital discharge
Hospital duration was measured to evaluate treatment efficiency
Time frame: Intraoperative
Number of participants with complications that occur during the procedure.
Time frame: Intraprocedural
Visibility during procedure by group, rating categories: Poor, Fair, Good, Very Good or Excellent
Time frame: Intraoperative
Occurrence of retropulsion by group
Time frame: Intraoperative
Performance rating of ability to reach stone fragments by group
Time frame: Intraoperative
Damage to scope or fiber by group
Time frame: Intraoperative
Fiber transmission (preserving energy transmission during lasing) by group
Boston Scientific Corporation
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03701009
Bile Duct Diseases, Biliary Tract Diseases
Lanzhou, Gansu, China
View Trial DetailsNCT07306819
Calculi, Female Urogenital Diseases
Cairo, Egypt
View Trial Details